14 - 15 November 2023 | Berlin, Germany
Targets & Cell Types in Immuno-Oncology
Europe 2023
14 - 15 November 2023 | Berlin, Germany

With new & emerging targets and drug candidates in immuno-oncology, key opinion leaders from pharmaceutical & biotech companies as well as academic & research organisations will be presenting on innovative approaches & methods for target identification & validation, such as AI-based strategies, novel checkpoint inhibitors and latest developments & case studies in cellular therapies : TILs, gamma deltas, myeloid cells 

Targets & Cell Types In Immuno-oncology Europe Congress

This Year's Event Includes...

  • Hear from and meet with the key innovators in novel
    targets & cell types in immuno-oncology. 2023 speakers include: Chief Executive Officer, TriCos Biotherapeutics; Chief Scientific Officer, Immutep;
    Director, Boehringer Ingelheim
  • Discuss the latest innovations in novel targets & target validation in immuno-oncology. Presentations will delve into AI-based approaches for target identification & validation; new technological approaches such as screening and CRISPR and new modalities approaches
  • Discover collaborative solutions to novel cell types to develop effective IO therapies. Delve into case studies in the utilisation of various cellular therapies such as TILs, suppressor & myeloid cells, preclinical tumour models and bispecific antibodies activating the immune system
  • Join a series of roundtables, panel discussions and workshops pertaining to the latest immuno-oncology research & development. Interactive sessions include: ‘Exploring Different Cell Types In The Tumour Microenvironment’; ‘Delivery of Novel Targets’ and many more

Agenda at a Glance

  • Computational approaches:
       » AI-based approaches for target identification & validation
       » Omics-based
  • Technological approaches to target identification: screening, CRISPR, functional genomics
  • Novel identification strategies
  • Exploring new immune checkpoint targets
  • Targeting the innate immune system
  • New modality approaches:
       » Immune checkpoint inhibitors
       » Immune adjuvant (STING agonists, novel immune-activating ADCs)
  • Case studies & latest developments in cellular therapies:
       » TILs
       » Gamma Deltas
       » Myeloid cells / Suppressor cells
      » B Cell therapies
      » iPSCs
  • Immune cell engagement & activation
  • Preclinical tumour models
  • Bispecific antibodies activating the immune system
  • Improving safety & efficacy

This event is co-located with Biomarkers Europe 2023 & Precision Oncology Europe 2023

The event provides an additional 25+ presentations on novel multiplex tools for biomarker analysis, latest cytometry tools & therapeutic applications as well as molecular analysis, multi-cancer early detection and testing, companion diagnostic development and biomarkers for clinical development and personalised patient treatment 

Key Speakers

Targets & Cell Types in Immuno-Oncology Europe 2023 brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook

Below are the key speakers for our Targets & Cell Types in Immuno-Oncology Europe 2023 event

Joanna Obacz
Senior Scientist, Translational Oncology
STORM Therapeutics
Kris Clark
Head of Biology
Grey Wolf Therapeutics
Jorg Rippmann
Director Pharmacology Cancer immunology and Immune Modulation
Boehringer Ingelheim
Oxford Global Conferences | Anil Thokura
Head of Immuno-Oncology, R&D
Orion Pharma

Event Features​

Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of event features and make the most of participation in a range of virtual experiences.

Poster Display

Enhance your attendance with an A0 Poster, based in our main networking hall

Networking Drinks

Relax after a busy first day at the event with access to the vibrant drinks reception

Event App

Our Event App features a personalisable agenda, peer-to-peer networking, OnDemand Presentations, solution provider content, and much more!

Thank you to our Sponsors

Oxford Global Conferences | Veracyte
Network & Programme Sponsor
Oxford Global Conferences | SGS Vitrology
Network & Programme Sponsor
Network & Programme Sponsor
Oxford Global Conferences | Propath UK Ltd
Network & Programme Sponsor
Oxford Global Conferences | Inoviv
Network & Programme Sponsor
Oxford Global Conferences | Indivumed
Network & Programme Sponsor
Oxford Global Conferences | Immunai
Network & Programme Sponsor
Oxford Global Conferences | Concept Life Sciences
Network & Programme Sponsor
Oxford Global Conferences | Biognosys AG
Network & Programme Sponsor
Oxford Global Conferences | Triburn Health
Bronze Sponsor
Oxford Global Conferences | Pixelgen
Bronze Sponsor
Oxford Global Conferences | Lunaphore Technologies
Bronze Sponsor
Oxford Global | Cytosurge
Bronze Sponsor
Oxford GlobalConferences | Cell Signaling Technology Europe B.V.
Bronze Sponsor
Oxford Global Conferences | Ultivue
Silver Sponsor
Oxford Global Conferences | Sengenics LLC
Silver Sponsor
Oxford Global Conferences | Scailyte AG
Silver Sponsor
Oxford Global Conferences | CellCarta
Silver Sponsor
Oxford Global Conferences | Bio-Rad Laboratories Ltd
Silver Sponsor
Oxford Global Conferences | ARC Regulatory
Silver Sponsor
Oxford Global Conferences | APIS Assay Technologies
Silver Sponsor
Gold Sponsor
Oxford Global Conferences | Labcorp
Gold Sponsor
Oxford Global Conferences | 10x Genomics
Gold Sponsor

Download Brochure

Full details regarding the Immuno Series UK are available for download in the Conference Brochure